Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Роль перекрестных исследований в оценке эффективности препаратов для лечения больных с заболеваниями сердца
Гиляревский С.Р., Голшмид М.В., Синицина И.И. Роль перекрестных исследований в оценке эффективности препаратов для лечения больных с заболеваниями сердца. Consilium Medicum. 2014; 16 (10): 95–98.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Полный текст
Список литературы
1. Fries R, Shariat K, Von Wilmowsky H, Bohm M. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation 2005; 112: 2980–5.
2. Grassi D, Necozione S, Lippi C et al. Cocoa Reduces Blood Pressure and Insulin Resistance and Improves Endothelium-Dependent Vasodilation in Hypertensives. Hypertension 2005; 46: 398–405.
3. Sudano I, Flammer AJ, Périat D et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation 2010; 122: 1789–96.
4. Bolk N, Visser TJ, Nijman J et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med 2010; 170: 1996–2003.
5. Noman A, Ang DSC, Ogston S et al. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010; 375 (9732): 2161–7.
6. Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart
J 2013; 34: 2949–3003.
7. Wittfeldt A, Emanuelsson H, Brandrup-Wognsen G et al. Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans. J Am Coll Cardiol 2013; 61: 723–7.
8. Deroubaix X, Lins RL, Lens S et al. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers. Int J Clin Pharmacol Ther 1996; 34: 61–70.
9. Steinmann E, Pfisterer M, Burkart F. Acute hemodynamic effects of bisoprolol, a new beta 1 selective adrenoreceptor blocking agent, in patients with coronary artery disease. J Cardiovasc Pharmacol 1986; 8: 1044–50.
2. Grassi D, Necozione S, Lippi C et al. Cocoa Reduces Blood Pressure and Insulin Resistance and Improves Endothelium-Dependent Vasodilation in Hypertensives. Hypertension 2005; 46: 398–405.
3. Sudano I, Flammer AJ, Périat D et al. Acetaminophen increases blood pressure in patients with coronary artery disease. Circulation 2010; 122: 1789–96.
4. Bolk N, Visser TJ, Nijman J et al. Effects of evening vs morning levothyroxine intake: a randomized double-blind crossover trial. Arch Intern Med 2010; 170: 1996–2003.
5. Noman A, Ang DSC, Ogston S et al. Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial. Lancet 2010; 375 (9732): 2161–7.
6. Montalescot G, Sechtem U, Achenbach S et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart
J 2013; 34: 2949–3003.
7. Wittfeldt A, Emanuelsson H, Brandrup-Wognsen G et al. Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans. J Am Coll Cardiol 2013; 61: 723–7.
8. Deroubaix X, Lins RL, Lens S et al. Comparative bioavailability of a metoprolol controlled release formulation and a bisoprolol normal release tablet after single oral dose administration in healthy volunteers. Int J Clin Pharmacol Ther 1996; 34: 61–70.
9. Steinmann E, Pfisterer M, Burkart F. Acute hemodynamic effects of bisoprolol, a new beta 1 selective adrenoreceptor blocking agent, in patients with coronary artery disease. J Cardiovasc Pharmacol 1986; 8: 1044–50.
Авторы
С.Р.Гиляревский, М.В.Голшмид, И.И.Синицина
Кафедра клинической фармакологии и терапии ГБОУ ДПО РМАПО Минздрава России, Москва
Кафедра клинической фармакологии и терапии ГБОУ ДПО РМАПО Минздрава России, Москва
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.